Gilead Sciences, Inc.

Gilead Sciences, Inc. is a biopharmaceutical company known for its research, development, and commercialization of innovative medicines. The company primarily focuses on antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, and influenza, addressing critical areas in the healthcare industry. Gilead's portfolio includes well-known treatments such as Truvada and Harvoni, which have been significant in managing and reducing the impact of viral diseases globally. Operating in a highly specialized sector, Gilead collaborates with healthcare professionals, government agencies, and non-profits to enhance patient outcomes and expand access to its therapies. The company plays a pivotal role in the market by continuously advancing pharmaceutical research, contributing to both public health and the medical community's understanding of viral pathogens. Headquartered in Foster City, California, Gilead Sciences is recognized for its commitment to innovation, impacting the lives of millions and maintaining a significant presence in the global biotechnology industry.